Loading organizations...
Hertility Health, a London, UK-based research-led femtech company, provides at-home hormone and fertility tests designed to offer a comprehensive view of women's reproductive health, spanning from menstruation through menopause. The company focuses on delivering science-backed, end-to-end reproductive diagnostics, bringing these services out of traditional lab settings to empower women globally with accessible health insights. This approach aims to facilitate early detection and understanding of reproductive health conditions. Notably, in 2023, 44% of its hormone and fertility test users received results indicative of a diagnosis, underscoring the platform's clinical relevance and impact. The organization's leadership includes CEO Dr Helen O’Neill, COO Dr Natalie Getreu, and CCO Deirdre O’Neill. Hertility Health was founded in 2020 by Dr Helen O’Neill, Dr Natalie Getreu, and Deirdre O’Neill.
Hertility Health has raised $9.0M across 1 funding round.
Hertility Health has raised $9.0M in total across 1 funding round.
Hertility Health has raised $9.0M in total across 1 funding round.
Hertility Health's investors include LocalGlobe, Mark Esiri, Global Innovation Fund, Outrun Ventures, Union Square Ventures, Martin Olczyk, Evelyn Bourke, Matt Robinson.
Hertility Health has raised $9.0M across 1 funding round. Most recently, it raised $9.0M Seed in June 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 1, 2021 | $9M Seed | LocalGlobe, Mark Esiri | Global Innovation Fund, Outrun Ventures, Union Square Ventures, Martin Olczyk, Evelyn Bourke, Matt Robinson | Announced |
Hertility Health is a UK-based femtech company that builds at‑home hormone and reproductive health diagnostics plus evidence‑based care pathways to make reproductive and hormonal health more *inclusive, data‑driven,* and accessible.[2][7]
High‑level overview
Origin story
Core differentiators
Role in the broader tech landscape
Quick take & future outlook
Concise reiteration: Hertility Health is a femtech company founded by academic and clinical experts to deliver inclusive, at‑home reproductive and hormonal diagnostics plus evidence‑based care pathways, with a research‑first approach aimed at shortening time‑to‑diagnosis and building more representative datasets for women’s health.[8][7]